{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:26:25Z","timestamp":1763036785343},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T00:00:00Z","timestamp":1379980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T00:00:00Z","timestamp":1379980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1038\/pcan.2013.36","type":"journal-article","created":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T10:15:37Z","timestamp":1380017737000},"page":"308-314","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men"],"prefix":"10.1038","volume":"16","author":[{"given":"L","family":"Hughes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ruth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T R","family":"Rebbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V N","family":"Giri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,24]]},"reference":[{"key":"BFpcan201336_CR1","unstructured":"American Cancer Society. Cancer Facts & Figures 2013. American Cancer Society: Atlanta, GA, USA, 2013."},{"key":"BFpcan201336_CR2","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/S0022-5347(05)64997-X","volume":"167","author":"O Bratt","year":"2002","unstructured":"Bratt O, Damber JE, Emanuelsson M, Gronberg H . Hereditary prostate cancer: clinical characteristics and survival. J Urol 2002; 167: 2423\u20132426.","journal-title":"J Urol"},{"key":"BFpcan201336_CR3","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1073\/pnas.89.8.3367","volume":"89","author":"BS Carter","year":"1992","unstructured":"Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC . Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89: 3367\u20133371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpcan201336_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0022-5347(17)35617-3","volume":"150","author":"BS Carter","year":"1993","unstructured":"Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993; 150: 797\u2013802.","journal-title":"J Urol"},{"key":"BFpcan201336_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.juro.2006.09.024","volume":"177","author":"IJ Powell","year":"2007","unstructured":"Powell IJ . Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol 2007; 177: 444\u2013449.","journal-title":"J Urol"},{"key":"BFpcan201336_CR6","doi-asserted-by":"publisher","first-page":"239460","DOI":"10.1155\/2011\/239460","volume":"2011","author":"SA Bigler","year":"2011","unstructured":"Bigler SA, Pound CR, Zhou X . A retrospective study on pathologic features and racial disparities in prostate cancer. Prostate Cancer 2011; 2011: 239460.","journal-title":"Prostate Cancer"},{"key":"BFpcan201336_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000019672","volume":"34","author":"O Bratt","year":"1998","unstructured":"Bratt O, Kristoffersson U, Olsson H, Lundgren R . Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor. Eur Urol 1998; 34: 19\u201324.","journal-title":"Eur Urol"},{"key":"BFpcan201336_CR8","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1056\/NEJMp1111894","volume":"365","author":"MF McNaughton-Collins","year":"2011","unstructured":"McNaughton-Collins MF, Barry MJ . One man at a time\u2014resolving the PSA controversy. N Engl J Med 2011; 365: 1951\u20131953.","journal-title":"N Engl J Med"},{"key":"BFpcan201336_CR9","first-page":"5875","volume":"18","author":"LG Gomella","year":"2011","unstructured":"Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T et al. Screening for prostate cancer: the current evidence and guidelines controversy. Can J Urol 2011; 18: 5875\u20135883.","journal-title":"Can J Urol"},{"key":"BFpcan201336_CR10","unstructured":"American Cancer Society guideline for the Early Detection of Prostate Cancer: Update 2012 Available from http:\/\/www.cancer.org\/Healthy\/FindCancerEarly\/CancerScreeningGuidelines\/american-cancer-society-guidelines-for-the-early-detection-of-cancer. (accessed 20 August 2012)."},{"key":"BFpcan201336_CR11","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1200\/JCO.2012.43.3441","volume":"30","author":"E Basch","year":"2012","unstructured":"Basch E, Oliver TK, Vickers A, Thompson I, Kantoff P, Parnes H et al. Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology provisional clinical opinion. J Clin Oncol 2012; 30: 3020\u20133025.","journal-title":"J Clin Oncol"},{"key":"BFpcan201336_CR12","unstructured":"Early Detection of Prostate Cancer. AUA Guideline 2013. Available from http:\/\/www.auanet.org\/education\/guidelines\/prostate-cancer-detection.cfm. (accessed 13 May 2013)."},{"key":"BFpcan201336_CR13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","volume":"6","author":"MD Jansson","year":"2012","unstructured":"Jansson MD, Lund AH . MicroRNA and cancer. Mol Oncol 2012; 6: 590\u2013610.","journal-title":"Mol Oncol"},{"key":"BFpcan201336_CR14","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1158\/0008-5472.CAN-07-0533","volume":"67","author":"KP Porkka","year":"2007","unstructured":"Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T . MicroRNA expression profiling in prostate cancer. Cancer Res 2007; 67: 6130\u20136135.","journal-title":"Cancer Res"},{"key":"BFpcan201336_CR15","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513\u201310518.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpcan201336_CR16","doi-asserted-by":"publisher","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","volume":"3","author":"S Gilad","year":"2008","unstructured":"Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008; 3: e3148.","journal-title":"PLoS One"},{"key":"BFpcan201336_CR17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1593\/neo.06202","volume":"8","author":"UP Kelavkar","year":"2006","unstructured":"Kelavkar UP, Parwani AV, Shappell SB, Martin WD . Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model. Neoplasia (New York, NY 2006; 8: 510\u2013522.","journal-title":"Neoplasia (New York, NY"},{"key":"BFpcan201336_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/dna.2007.0600","volume":"26","author":"Y Liu","year":"2007","unstructured":"Liu Y, Lin N, Huang L, Xu Q, Pang G . Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer. DNA Cell Biol 2007; 26: 613\u2013618.","journal-title":"DNA Cell Biol"},{"key":"BFpcan201336_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.91","volume":"40","author":"G Thomas","year":"2008","unstructured":"Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008; 40: 310\u2013315.","journal-title":"Nat Genet"},{"key":"BFpcan201336_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/pros.20211","volume":"64","author":"R Mukherjee","year":"2005","unstructured":"Mukherjee R, Bartlett JM, Krishna NS, Underwood MA, Edwards J . Raf-1 expression may influence progression to androgen insensitive prostate cancer. Prostate 2005; 64: 101\u2013107.","journal-title":"Prostate"},{"key":"BFpcan201336_CR21","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/pros.21197","volume":"70","author":"E Comperat","year":"2010","unstructured":"Comperat E, Roupret M, Drouin SJ, Camparo P, Bitker MO, Houlgatte A et al. Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy. Prostate 2010; 70: 1622\u20131627.","journal-title":"Prostate"},{"key":"BFpcan201336_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281\u2013297.","journal-title":"Cell"},{"key":"BFpcan201336_CR23","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1093\/carcin\/bgn116","volume":"29","author":"K Chen","year":"2008","unstructured":"Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W . Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 2008; 29: 1306\u20131311.","journal-title":"Carcinogenesis"},{"key":"BFpcan201336_CR24","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1158\/1055-9965.EPI-12-0707","volume":"21","author":"K Batai","year":"2012","unstructured":"Batai K, Shah E, Murphy AB, Newsome J, Ruden M, Ahaghotu C et al. Fine-mapping of IL16 gene and prostate cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 2012; 21: 2059\u20132068.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFpcan201336_CR25","doi-asserted-by":"publisher","first-page":"e24241","DOI":"10.1371\/journal.pone.0024241","volume":"6","author":"BW Tse","year":"2011","unstructured":"Tse BW, Russell PJ, Lochner M, Forster I, Power CA . IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms. PLoS One 2011; 6: e24241.","journal-title":"PLoS One"},{"key":"BFpcan201336_CR26","doi-asserted-by":"publisher","first-page":"16189","DOI":"10.1074\/jbc.M111936200","volume":"277","author":"S Tang","year":"2002","unstructured":"Tang S, Bhatia B, Maldonado CJ, Yang P, Newman RA, Liu J et al. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J Biol Chem 2002; 277: 16189\u201316201.","journal-title":"J Biol Chem"},{"key":"BFpcan201336_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/dna.2007.0650","volume":"27","author":"D Landi","year":"2008","unstructured":"Landi D, Gemignani F, Barale R, Landi S . A catalog of polymorphisms falling in microRNA-binding regions of cancer genes. DNA Cell Biol 2008; 27: 35\u201343.","journal-title":"DNA Cell Biol"},{"key":"BFpcan201336_CR28","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.juro.2007.07.010","volume":"178","author":"VN Giri","year":"2007","unstructured":"Giri VN, Beebe-Dimmer J, Buyyounouski M, Konski A, Feigenberg SJ, Uzzo RG et al. Prostate cancer risk assessment program: a 10-year update of cancer detection. J Urol 2007; 178: 1920\u20131924.","journal-title":"J Urol"},{"issue":"Part 1","key":"BFpcan201336_CR29","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/S0022-5347(01)62789-7","volume":"160","author":"LA Eskew","year":"1998","unstructured":"Eskew LA, Woodruff RD, Bare RL, McCullough DL . Prostate cancer diagnosed by the 5 region biopsy method is significant disease. J Urol 1998; 160 (Part 1): 794\u2013796.","journal-title":"J Urol"},{"key":"BFpcan201336_CR30","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/thx.54.10.911","volume":"54","author":"M Laan","year":"1999","unstructured":"Laan M, Qvarfordt I, Riise GC, Andersson BA, Larsson S, Linden A . Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes. Thorax 1999; 54: 911\u2013916.","journal-title":"Thorax"},{"key":"BFpcan201336_CR31","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.rmed.2009.05.023","volume":"103","author":"N Rovina","year":"2009","unstructured":"Rovina N, Dima E, Gerassimou C, Kollintza A, Gratziou C, Roussos C . IL-18 in induced sputum and airway hyperresponsiveness in mild asthmatics: effect of smoking. Respir Med 2009; 103: 1919\u20131925.","journal-title":"Respir Med"},{"key":"BFpcan201336_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1475-2840-10-110","volume":"10","author":"TB Opstad","year":"2011","unstructured":"Opstad TB, Pettersen AA, Arnesen H, Seljeflot I . Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A\/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study. Cardiovasc Diabetol 2011; 10: 110.","journal-title":"Cardiovasc Diabetol"},{"key":"BFpcan201336_CR33","volume-title":"Statistics with Applications in Biology and Geology","author":"P Blaesild","year":"2002","unstructured":"Blaesild P, Grandfeldt J . Statistics with Applications in Biology and Geology 1st edn. Chapman & Hall\/CRC Press: New York, NY and Englewood Cliffs, NJ, 2002."},{"key":"BFpcan201336_CR34","doi-asserted-by":"publisher","first-page":"e18067","DOI":"10.1371\/journal.pone.0018067","volume":"6","author":"Z Fang","year":"2011","unstructured":"Fang Z, Rajewsky N . The impact of miRNA target sites in coding sequences and in 3'UTRs. PLoS One 2011; 6: e18067.","journal-title":"PLoS One"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/pcan201336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pcan201336","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pcan201336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:33:49Z","timestamp":1648676029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pcan201336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,24]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["BFpcan201336"],"URL":"https:\/\/doi.org\/10.1038\/pcan.2013.36","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,24]]},"assertion":[{"value":"16 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}